ANRO

Alto Neuroscience, Inc.

A clinical-stage biopharmaceutical company working in precision psychiatry, Alto Neuroscience uses brain imaging and biomarkers to match people with mental health treatments likely to work for them, rather than the usual trial-and-error approach. It was founded in 2019 by Dr. Amit Etkin, a psychiatrist and neuroscientist and former Stanford professor, building on his years of research. A naming quirk: "Alto" may nod to the Latin for "high" — and to Palo Alto, where Etkin worked at the VA medical center.